Finance Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 BeatNovember 17, 20250 GeneDx Holdings Corp. (NASDAQ:WGS) is without doubt one of the greatest digital well being shares to purchase now. On October…
